Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HBD3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.420 |
CLV_PCSK_FUR_1 | 224 | 228 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.572 |
CLV_PCSK_SKI1_1 | 274 | 278 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.403 |
CLV_Separin_Metazoa | 161 | 165 | PF03568 | 0.466 |
DOC_CYCLIN_RxL_1 | 47 | 57 | PF00134 | 0.488 |
DOC_MAPK_gen_1 | 118 | 125 | PF00069 | 0.373 |
DOC_MAPK_gen_1 | 47 | 56 | PF00069 | 0.466 |
DOC_MAPK_gen_1 | 5 | 14 | PF00069 | 0.592 |
DOC_MAPK_MEF2A_6 | 118 | 127 | PF00069 | 0.369 |
DOC_PP4_FxxP_1 | 14 | 17 | PF00568 | 0.512 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.353 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.464 |
LIG_14-3-3_CanoR_1 | 224 | 232 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 274 | 279 | PF00244 | 0.397 |
LIG_eIF4E_1 | 115 | 121 | PF01652 | 0.382 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.486 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.409 |
LIG_FHA_1 | 289 | 295 | PF00498 | 0.389 |
LIG_FHA_2 | 253 | 259 | PF00498 | 0.582 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.456 |
LIG_LIR_Gen_1 | 77 | 83 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 230 | 235 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 269 | 273 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 284 | 289 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 77 | 81 | PF02991 | 0.424 |
LIG_Pex14_1 | 203 | 207 | PF04695 | 0.460 |
LIG_Pex14_2 | 209 | 213 | PF04695 | 0.519 |
LIG_PTB_Apo_2 | 264 | 271 | PF02174 | 0.443 |
LIG_PTB_Phospho_1 | 264 | 270 | PF10480 | 0.440 |
LIG_Rb_LxCxE_1 | 297 | 308 | PF01857 | 0.322 |
LIG_SH2_GRB2like | 265 | 268 | PF00017 | 0.444 |
LIG_SH2_NCK_1 | 289 | 293 | PF00017 | 0.354 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.429 |
LIG_SH2_STAP1 | 241 | 245 | PF00017 | 0.414 |
LIG_SH2_STAP1 | 289 | 293 | PF00017 | 0.258 |
LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.509 |
LIG_SH2_STAT3 | 235 | 238 | PF00017 | 0.409 |
LIG_SH2_STAT3 | 67 | 70 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.565 |
LIG_SH2_STAT5 | 289 | 292 | PF00017 | 0.338 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.554 |
LIG_SUMO_SIM_par_1 | 119 | 124 | PF11976 | 0.490 |
LIG_TRAF2_1 | 187 | 190 | PF00917 | 0.399 |
LIG_TRAF2_1 | 96 | 99 | PF00917 | 0.512 |
LIG_WRC_WIRS_1 | 270 | 275 | PF05994 | 0.434 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.593 |
MOD_CK1_1 | 269 | 275 | PF00069 | 0.491 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.431 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.526 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.523 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.487 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.665 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.491 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.492 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.430 |
MOD_N-GLC_1 | 294 | 299 | PF02516 | 0.502 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.441 |
MOD_NEK2_1 | 287 | 292 | PF00069 | 0.402 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.375 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.472 |
MOD_PIKK_1 | 81 | 87 | PF00454 | 0.533 |
MOD_PK_1 | 119 | 125 | PF00069 | 0.367 |
MOD_PK_1 | 259 | 265 | PF00069 | 0.341 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.564 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.498 |
MOD_PKA_2 | 258 | 264 | PF00069 | 0.460 |
MOD_Plk_1 | 259 | 265 | PF00069 | 0.549 |
MOD_Plk_1 | 266 | 272 | PF00069 | 0.516 |
MOD_Plk_1 | 294 | 300 | PF00069 | 0.411 |
MOD_Plk_2-3 | 150 | 156 | PF00069 | 0.478 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.507 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.360 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.459 |
MOD_SUMO_rev_2 | 41 | 49 | PF00179 | 0.345 |
TRG_DiLeu_BaLyEn_6 | 70 | 75 | PF01217 | 0.336 |
TRG_ENDOCYTIC_2 | 270 | 273 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.420 |
TRG_ER_diArg_1 | 223 | 226 | PF00400 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 186 | 190 | PF00026 | 0.406 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILS3 | Leptomonas seymouri | 72% | 100% |
A0A0S4KKA1 | Bodo saltans | 37% | 93% |
A0A1X0PBI9 | Trypanosomatidae | 42% | 100% |
A0A3R7M5H3 | Trypanosoma rangeli | 45% | 100% |
A0A3S7X8I2 | Leishmania donovani | 83% | 100% |
A4IAI1 | Leishmania infantum | 83% | 100% |
C9ZLQ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9B5K5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4Q2D1 | Leishmania major | 82% | 100% |
V5BRF3 | Trypanosoma cruzi | 45% | 100% |